Picroside II Exerts a Neuroprotective Effect by Inhibiting mPTP Permeability and EndoG Release after Cerebral Ischemia/Reperfusion Injury in Rats

J Mol Neurosci. 2018 Jan;64(1):144-155. doi: 10.1007/s12031-017-1012-z. Epub 2017 Dec 18.

Abstract

Mitochondrial membrane permeability is closely related to cerebral ischemia/reperfusion (I/R) injury. This paper explored the neuroprotective effect of picroside II (Picr), which inhibits the permeability of mitochondrial permeability transition pore (mPTP) and endonuclease G (EndoG) release from mitochondria into cytoplasm after cerebral I/R in rats. After 2 h of cerebral ischemia and 24 h of reperfusion in rats with different intervention measures, the neurobehavioral function, infarction volume, and reactive oxygen species (ROS) content in brain tissues were observed by modified neurological severity scale (mNSS), triphenyl tetrazolium chloride (TTC) staining, and enzyme-linked immunosorbent assay, respectively. The permeability of mPTP was assayed using spectrophotometry. The morphology and apoptotic cells of brain tissues were observed by hematoxylin-eosin staining and terminal deoxynucleotidyl transferase dUTP nick end labeling assay, respectively. The expressions of EndoG and voltage-dependent anion channel 1 (VDAC1) were determined by immunohistochemical assay and western blot. The Picr group exhibited clear decreases in mNSS scores, ROS content, number of apoptotic cells, mPTP permeability and expression of VDAC1, and EndoG in cytoplasm and nuclei, and the morphology of brain tissue was improved as compared with the model group (P < 0.05). Picr could attenuate cerebral I/R injury by downregulating the expression of VDAC1 and decreasing the permeability of mPTP, thereby inhibiting EndoG release from mitochondria into cytoplasm.

Keywords: Endonuclease G; Ischemia/reperfusion; Mitochondrial permeability transition pore; PicrosideII; Voltage-dependent anion channel 1.

MeSH terms

  • Animals
  • Apoptosis
  • Cinnamates / pharmacology*
  • Cinnamates / therapeutic use
  • Endodeoxyribonucleases / metabolism*
  • Infarction, Middle Cerebral Artery / drug therapy*
  • Infarction, Middle Cerebral Artery / metabolism
  • Iridoid Glucosides / pharmacology*
  • Iridoid Glucosides / therapeutic use
  • Male
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondrial Membrane Transport Proteins / metabolism*
  • Mitochondrial Permeability Transition Pore
  • Neuroprotective Agents / pharmacology*
  • Neuroprotective Agents / therapeutic use
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Voltage-Dependent Anion Channel 1 / metabolism

Substances

  • Cinnamates
  • Iridoid Glucosides
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • Vdac1 protein, rat
  • picroside II
  • Voltage-Dependent Anion Channel 1
  • Endodeoxyribonucleases
  • endonuclease G